Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Do you find yourself saying any of these?
In recent research, 33%of patients experience substandard responses to their prescribed antidepressants. This statistic shows that you may be receiving little to no benefit in relieving your depressive symptoms. There are many causes of this including a new medical condition, stress, or even genetics. The answer to this problem is not to stop taking your antidepressant completely, but to start thinking about other options. Don’t accept your depression as being normal. For more information, reach out to the Institute for Advanced Medical Researchat 770-817-9200.
You Might Also Enjoy...
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Pain can be depressing, and depression creates and exacerbates pain. This cycle can be a dangerous one. In fact, people afflicted by chronic pain are three times more likely to develop psychiatric disorders (most often anxiety or mood disorders).
Depression is a mental disorder that both men and women struggle with. However, in the case of men, the disorder can look very differently that it looks in women.
Anyone that has had Chickenpox, even if it was all the way back in childhood, now lives with the risk of experiencing Shingles when they enter their later years. And what does that have to do with Fibromyalgia?!
If you or a loved one are still struggling with depression even on medication, you are not the only one!
Fibromyalgia is painful, difficult to diagnose and has limited treatment options. But there are always new drugs being developed! #Fibro #FibroATL #FibroAlpharetta #FibroOptions